NASDAQ: ORKARUSSELL2000

Oruka Therapeutics, Inc.

Healthcare · Biotechnology · Headquartered in Menlo Park, US

Price

Loading chart…

Overview

Oruka Therapeutics, Inc. functions as a biotechnology firm primarily dedicated to creating groundbreaking monoclonal antibody therapies. These treatments are designed to address Psoriasis (PsO) along with various other inflammatory and immunological (I&I) conditions. Its current development portfolio includes ORKA-001 and ORKA-002. The company's main operations are based in Menlo Park, CA.

History & business model

This section is waiting to be written.

InvestWiki is community-edited. Contribute a plain-English history of Oruka Therapeutics, Inc., its business model, key products, and controversies.

Write this articleSign in required. Edits go to moderator review.View history →